26 active trials 10 recruiting 9 Phase 3 4 changes in 30 days
4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.
Results posted: Oct 1, 2026
ViiV HealthcarePhase 4 NCT05514509 Registry history of NCT05514509 on ClinicalTrials.gov (opens the registry)
Updated
Trial sites expanded: 88 → 108 locations
ViiV HealthcarePhase 3 NCT07650916 Registry history of NCT07650916 on ClinicalTrials.gov (opens the registry)
Updated
Completion pushed from Jan 10, 2029 to Aug 30, 2029
ViiV HealthcarePhase 2 NCT06741397 Registry history of NCT06741397 on ClinicalTrials.gov (opens the registry)
Updated
Final enrollment: 107 participants (planned 130)
ViiV HealthcarePhase 1 NCT07053384 Registry history of NCT07053384 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-16 | NCT07822477 A Study to Investigate Safety, Tolerability and Pharmacokinetics of VH5356136 in Adult… | Phase 1 | Not Yet Recruiting |
| 2026-09-14 | NCT07818915 A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in… | Phase 1 | Not Yet Recruiting |
| Phase 1 | 11 | |
| Phase 1/2 | 2 | |
| Phase 2 | 4 | |
| Phase 3 | 9 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07650916 | A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra… | HIV Infections | Recruiting | 2026-09-28 |
| NCT07393659 | A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or… | HIV Infections | Recruiting | 2026-08-14 |
| NCT06694805 | A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) +… | HIV Infections | Active, Not Recruiting | 2026-10-01 |
| NCT02362503 | Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients | HIV Infections | Active, Not Recruiting | 2026-08-21 |
| NCT02938520 | Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular… | HIV Infections | Active, Not Recruiting | 2026-07-30 |
| NCT06134362 | Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure… | HIV Infections | Active, Not Recruiting | 2026-07-30 |
| NCT02951052 | Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting… | Infection, Human Immunodeficiency Virus | Active, Not Recruiting | 2026-07-08 |
| NCT05979311 | A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2… | HIV | Active, Not Recruiting | 2026-07-02 |
| NCT03299049 | Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting… | HIV Infections | Active, Not Recruiting | 2025-08-22 |
| Phase 2 | ||||
| NCT07202546 | A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1… | HIV Infections | Recruiting | 2026-07-23 |
| NCT06741397 | A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation… | HIV Infections | Active, Not Recruiting | 2026-10-05 |
| NCT07816250 | A Phase 2b Study Evaluating VH4011499 Capsid Inhibitor Long-Acting Injectable Plus… | HIV Infections | Not Yet Recruiting | 2026-09-11 |
| NCT05996471 | A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir… | HIV Infections | Active, Not Recruiting | 2026-07-29 |
| Phase 1/2 | ||||
| NCT07275606 | A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1 | HIV Infections | Recruiting | 2026-05-19 |
| NCT05674656 | Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics | HIV Infections | Recruiting | 2024-09-19 |
| Phase 1 | ||||
| NCT06310551 | First Time in Human Study of Long Acting VH4524184 Formulations | HIV Infections | Recruiting | 2026-08-10 |
| NCT07525544 | A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants | HIV Infections | Recruiting | 2026-07-13 |
| NCT07636928 | Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 | HIV Infections | Recruiting | 2026-07-02 |
| NCT05418868 | A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting… | HIV Infections | Recruiting | 2025-12-18 |
| NCT06724640 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to… | HIV Infections | Recruiting | 2025-10-29 |
| NCT07053384 | A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce… | HIV Infections | Active, Not Recruiting | 2026-09-28 |
| NCT07822477 | A Study to Investigate Safety, Tolerability and Pharmacokinetics of VH5356136 in Adult… | HIV Infections | Not Yet Recruiting | 2026-09-16 |
| NCT07818915 | A Study to Investigate Pharmacokinetics (PK), Safety, and Tolerability of VH4367310 in… | HIV Infections | Not Yet Recruiting | 2026-09-14 |
| NCT06652958 | A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody… | HIV Infections | Active, Not Recruiting | 2026-06-30 |
| NCT06970223 | A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections… | HIV Infections | Active, Not Recruiting | 2025-11-28 |